neonatal screening
Jump to navigation
Jump to search
Procedure
- standard protocol to screen for:
- other screening may include screening for:
* Only Idaho & Wyoming do not have mandatory screening
More general terms
More specific terms
- amino acidemia newborn screen
- beta-galactosidase blood spot
- branched chain keto-acid dehydrogenase complex in blood
- citrulline/arginine in dried blood spot
- citrulline/phenylalanine in dried blood spot
- citrulline/tyrosine in dried blood spot
- creatine kinase MM in blood; GSP Neonatal Creatine Kinase-MM kit
- endocrine disorder newborn screen
- fatty acid oxidation defects newborn screen
- galactose in blood spot
- galactosemia newborn screen
- hemoglobin disorders newborn screen
- hemolytic disease of the newborn screen
- lysosomal storage disorder screeing (Seeker system)
- medium/short chain acyl-CoA dehydrogenase deficiency newborn screen
- monolysocardiolipin/Cardiolipin in dried blood spot
- organic acids newborn screen
- phenylalanine in dried blood spot
- phenylalanine/tyrosine in blood
- screening for cystic fibrosis
- screening for galactosemia
- screening for phenylketonuria
- T-cell receptor excision circle in dried blood spot
- thyrotropin (TSH) in blood spot
- thyroxine (T4) in dried blood spot
- tyrosine in dried blood spot
- tyrosine/phenylalanine in blood
Additional terms
Components
References
- ↑ 1.0 1.1 Thangaratinam S et al Pulse oximetry screening for critical congenital heart defects in asymptomatic newborn babies: a systematic review and meta-analysis The Lancet, Early Online Publication, 2 May 2012 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/22554860 <Internet> http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(12)60107-X/fulltext
Centers for Disease Control and Prevention Protocol. Methods and Screening Algorithm. Screening for Critical Congenital Heart Defects http://www.cdc.gov/ncbddd/pediatricgenetics/pulse.html - ↑ 2.0 2.1 Abouk R, Grosse SD, Ailes EC, Oster ME. Association of US State Implementation of Newborn Screening Policies for Critical Congenital Heart Disease With Early Infant Cardiac Deaths. JAMA. 2017;318(21):2111-2118. PMID: https://www.ncbi.nlm.nih.gov/pubmed/29209720 https://jamanetwork.com/journals/jama/article-abstract/2664999
Kemper AR, Lam WKK, Bocchini JA Jr The Success of State Newborn Screening Policies for Critical Congenital Heart Disease. JAMA. 2017;318(21):2087-2088. PMID: https://www.ncbi.nlm.nih.gov/pubmed/29209703 https://jamanetwork.com/journals/jama/article-abstract/2664979 - ↑ Kid's Health http://kidshealth.org/parent/system/medical/newborn_screening_tests.html